Pharmacyclics Divisional Patent Application Upheld by Calcutta High Court
Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.
2 articles
Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.
Patent Docs is a leading source for biotech and pharma patent law updates, offering expert analyses and timely news. Authored by experienced practitioners, it serves as an essential…